CPT® Code 81230

The CPT® Code 81230 pertains to the gene analysis of CYP3A4, which is a member of the cytochrome P450 family 3 subfamily A. This gene plays a crucial role in drug metabolism, as it encodes enzymes that are responsible for the biotransformation of various medications. The analysis specifically targets common variants of the CYP3A4 gene, such as *2 and *22, which can significantly influence how individuals metabolize certain drugs. The CYP3A4 gene is located on the long (q) arm of chromosome 7 at position 22.1. Understanding the genetic variations in this gene is essential for predicting an individual's response to medications, particularly those that are commonly prescribed, including acetaminophen, opioids, statins, oral contraceptives, and chemotherapeutic agents. The presence of specific variants may indicate a reduced ability to metabolize these drugs, which can lead to an increased risk of adverse drug reactions or toxicity. Conversely, the absence of these variants typically suggests that a patient will metabolize drugs at a normal rate, allowing for standard dosing protocols. The gene analysis is performed using a sample obtained from peripheral blood or buccal mucosa, which is collected through a separate reportable procedure. The testing method employed is multiplex polymerase chain reaction (PCR) combined with primer extensions, ensuring accurate identification of the common variants in the CYP3A4 gene. This genetic information is vital for healthcare providers to tailor medication plans and monitor patients effectively, especially those with a personal or family history of adverse drug reactions.